162 related articles for article (PubMed ID: 25715243)
41. Treatment of hereditary angioedema: a review (CME).
Bhardwaj N; Craig TJ
Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
[TBL] [Abstract][Full Text] [Related]
42. Current characteristics associated with hereditary angioedema attacks and treatment: the home infusion based patient experience.
Tachdjian R; Banerji A; Guyer A; Morphew T
Allergy Asthma Proc; 2015; 36(2):151-9. PubMed ID: 25715244
[TBL] [Abstract][Full Text] [Related]
43. Current drugs in early development for hereditary angioedema: potential for effective treatment.
Bork K
Expert Opin Investig Drugs; 2014 Jul; 23(7):887-91. PubMed ID: 24797354
[TBL] [Abstract][Full Text] [Related]
44. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007.
Zilberberg MD; Jacobsen T; Tillotson G
Allergy Asthma Proc; 2010; 31(6):511-9. PubMed ID: 20964950
[TBL] [Abstract][Full Text] [Related]
45. Managed care implications of hereditary angioedema.
Cardarelli W
Am J Manag Care; 2013 Jun; 19(7 Suppl):s119-24. PubMed ID: 23844784
[TBL] [Abstract][Full Text] [Related]
46. Target levels of functional C1-inhibitor in hereditary angioedema.
Hack CE; Relan A; van Amersfoort ES; Cicardi M
Allergy; 2012 Jan; 67(1):123-30. PubMed ID: 21923668
[TBL] [Abstract][Full Text] [Related]
47. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
[TBL] [Abstract][Full Text] [Related]
48. Hereditary angioedema treatment options: the availability of new therapies.
Aberer W
Ann Med; 2012 Sep; 44(6):523-9. PubMed ID: 22784006
[TBL] [Abstract][Full Text] [Related]
49. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
Shapiro RS; Zacek L
J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
[TBL] [Abstract][Full Text] [Related]
50. An update on hereditary angioedema.
Hsu D; Shaker M
Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
[TBL] [Abstract][Full Text] [Related]
51. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
52. [Hereditary angioedema. Treatment of acute attacks in Argentina].
Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
54. Assessment of hereditary angioedema treatment risks.
Kalaria S; Craig T
Allergy Asthma Proc; 2013; 34(6):519-22. PubMed ID: 24169059
[TBL] [Abstract][Full Text] [Related]
55. Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
González-Quevedo T; Larco JI; Marcos C; Guilarte M; Baeza ML; Cimbollek S; López-Serrano MC; Piñero-Saavedra M; Rubio M; Caballero T
J Investig Allergol Clin Immunol; 2016; 26(3):161-7. PubMed ID: 27326983
[TBL] [Abstract][Full Text] [Related]
56. Use of ecallantide in pediatric hereditary angioedema.
MacGinnitie AJ; Davis-Lorton M; Stolz LE; Tachdjian R
Pediatrics; 2013 Aug; 132(2):e490-7. PubMed ID: 23878046
[TBL] [Abstract][Full Text] [Related]
57. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
Nzeako UC; Longhurst HJ
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
[TBL] [Abstract][Full Text] [Related]
58. Hereditary Angioedema patient experiences of medication use and emergency care.
Burton AE; Lindsay-Wiles I; Herron D; Owen A; Elliott J; Metcalfe A; Diwakar L
Int Emerg Nurs; 2023 Nov; 71():101339. PubMed ID: 37713946
[TBL] [Abstract][Full Text] [Related]
59. Analysis of hereditary angioedema attacks requiring a second dose of ecallantide.
Li HH; Campion M; Craig TJ; Soteres DF; Riedl M; Lumry WR; MacGinnitie AJ; Shea EP; Bernstein JA
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):168-72. PubMed ID: 23548526
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
